Notably, SLC6A12, uniquely identified as a DEG across all three comparison groups (AD versus CN, AD versus MCI, and MCI versus CN), exhibited a significant negative correlation with AD risk in both cohorts (HRROSMAP = 0.784, HRADNI = 0.673). This evidence concerns the gene SLC6A12 and Alzheimer disease.